Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeadaches are one of the more commonly reported side effects of Wegovy, particularly in the first few weeks of treatment or after a dose step-up. They affect a meaningful minority of people and usually settle on their own. That said, knowing why they happen, what helps, and which symptoms need prompt medical attention makes the experience far less unsettling. Wegovy (semaglutide) is a prescription-only medicine; a prescriber assesses whether it is suitable for you and discusses the full side-effect profile before any treatment begins. Our complete guide to Wegovy side effects covers the broader picture, but this page focuses specifically on headaches on Wegovy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When people start reporting headaches on Wegovy, there is rarely a single cause. The NHS medicines page for semaglutide lists headache as a known side effect, and it clusters predictably around two moments: the first few injections and the days following each dose increase.
The most plausible mechanism is indirect. Wegovy slows gastric emptying and suppresses appetite, which means many people eat and drink noticeably less than usual, particularly in the first week of a new dose. Mild dehydration is a very efficient headache trigger. Reduced calorie intake can also cause a transient dip in blood glucose, another well-established headache driver. Neither of these is specific to semaglutide; they are side effects of the physiological changes the medicine creates.
There is also a direct pharmacological component. Semaglutide acts on GLP-1 receptors found in the gut and the central nervous system. Changes in vascular tone and neurological signalling during the adjustment period may contribute to head pain in some people, and if you want to understand exactly why that happens, our page on whether Wegovy causes headaches covers the mechanisms in detail. This tends to resolve as the body adapts to the new dose level. For a deeper look at how semaglutide works, the Wegovy treatment overview explains the mechanism in plain terms.
Worth noting: headaches caused by simply eating less or drinking less are correctable without touching your dose.
Most management advice for Wegovy-related headaches comes down to supporting the body through the adjustment period rather than fighting the medicine itself.
Hydration first. Aim to keep fluid intake steady even when appetite and thirst feel blunted. Plain water is the obvious choice; some people find warm drinks easier when nausea is present. If vomiting is reducing your ability to keep fluids down, that is a separate concern covered in the next section.
Don't skip meals entirely. A small, protein-rich meal or snack can stabilise blood glucose and reduce the headache window. Appetite suppression does not mean you should stop eating; it means the amount changes. Our page on minimising Wegovy side effects covers nutrition and timing in more detail.
Standard pain relief. Paracetamol at the usual adult dose is generally appropriate for a straightforward headache during treatment. Check with your pharmacist or prescriber before using ibuprofen or other anti-inflammatory medicines if there are any other relevant health factors.
Rest and pacing. Injecting later in the day means any peak side effects arrive overnight when you're resting rather than mid-morning. Some people find this simple timing shift reduces the impact of headaches and nausea together. Discuss timing adjustments with your prescriber rather than making them unilaterally.
For further context on cost if you are weighing up whether to continue treatment, Wegovy pricing in the UK explains what private prescriptions typically involve.
The vast majority of headaches during Wegovy treatment are mild, predictable and self-limiting. A small number are not, and it matters to know the difference.
Get same-day medical help (contact your GP, call 111, or go to A&E if needed) if your headache:
The MHRA's Yellow Card scheme lets patients report suspected side effects directly to the regulator; if you experience a headache reaction you consider serious or unexpected, you can file a report there. It contributes to ongoing medicines safety monitoring. Our prescribers also welcome clinical queries through the support channel; aftercare is included, seven days a week.
Persistent, moderate headaches that are not dangerous but are significantly affecting your quality of life deserve a conversation rather than quiet endurance. A prescriber can consider whether your current dose is advancing too quickly, whether there are contributing factors in your health picture, or whether a brief dose pause is appropriate. These are clinical decisions made for your specific situation.
Questions our prescribers hear regularly include whether headaches mean someone should stop Wegovy altogether. In most cases the answer is no, the headaches are transient and manageable. But that assessment belongs with a clinician who knows your full health history, not a forum or a search engine.
If you are considering starting treatment and want to discuss this and other side effects in advance, checking your eligibility with our prescribers is the right starting point. The consultation is free, and suitability and side effects are discussed before anything is prescribed. Once approved and dispatched, your pen arrives via DPD the next working day in plain, unmarked packaging, tracked, so you know exactly when to expect it. You can read more about headaches and semaglutide generally if you want the broader clinical context before your consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.